Advertisement
Correspondence and Communications| Volume 78, P60-61, March 2023

Novel method of securing non-textured tabbed anatomical implants in breast reconstruction

Published:February 03, 2023DOI:https://doi.org/10.1016/j.bjps.2023.01.014
      Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has rapidly become a significant concern for women with textured breast implants in the last twenty years since it was first reported.
      • Cordeiro P.G.
      • Ghione P.
      • Ni A.
      • et al.
      Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
      The incidence appears to depend on texturization but a recent prospective cohort study reports the overall risk of BIA-ALCL is 1/355 women or 0.311 cases per 1000 person years.
      • Cordeiro P.G.
      • Ghione P.
      • Ni A.
      • et al.
      Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
      The highest overall risk reports is associated with the use of macro-textured implants.
      • Collett D.J.
      • Rakhorst H.
      • Lennox P.
      • Magnusson M.
      • Cooter R.
      • Deva A.K.
      Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants.
      This risk was felt to be significant enough that the US Food and Drug Administration (FDS) recalled Allergan Natrelle BIOCELL-textured breast implants in July 2019.

      Administration UFaD. The FDA requests Allergan voluntarily recall Natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients. In: Administration UFaD (ed.), FDA safety communication. US2019.

      This has triggered a shift away from the accepted paradigm of textured anatomical implants back to the traditional smooth round implant.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cordeiro P.G.
        • Ghione P.
        • Ni A.
        • et al.
        Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
        J Plast Reconstr Aesthet Surg. 2020; 73: 841-846
        • Collett D.J.
        • Rakhorst H.
        • Lennox P.
        • Magnusson M.
        • Cooter R.
        • Deva A.K.
        Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants.
        Plast Reconstr Surg. 2019; 143: 30S-40S
      1. Administration UFaD. The FDA requests Allergan voluntarily recall Natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients. In: Administration UFaD (ed.), FDA safety communication. US2019.

        • Calobrace M.B.
        • Schwartz M.R.
        • Zeidler K.R.
        • Pittman T.A.
        • Cohen R.
        • Stevens W.G.
        Long-term safety of textured and smooth breast implants.
        Aesthet Surg J. 2017; 38: 38-48
        • Reitsamer R.
        • Peintinger F.
        Prepectoral implant placement and complete coverage with porcine acellular dermal matrix: a new technique for direct-to-implant breast reconstruction after nipple-sparing mastectomy.
        J Plast Reconstr Aesthet Surg. 2015; 68: 162-167